essential phospholipids

Small moleculeexperimental

Clinical trial activity

1 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1

Earliest trial started Jun 1, 2010 (NCT01148576)

Timeline

No events for the selected filters.

Indications

Approved for

Mechanism of action

  • Unspecified targetSupplementation

    supplementation

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • cholinephospholipids
  • essential 303 forte
  • essentiale
  • essentiale 303
  • essentiale forte
  • essential phospholipids
  • essential phospholipids

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01148576Phase 4Jun 1, 2010Zhejiang University
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Zhejiang UniversityAcademic/Hospital1112010
1 organizations
Page 1 / 1